Results 191 to 200 of about 83,600 (312)

Patient considerations in the treatment of cervical dystonia: focus on botulinum toxin type A

Patient Preference and Adherence, 2015
Reversa R Mills, Fernando L Pagan Department of Neurology, Movement Disorders and Neurorestoration Division, Georgetown University Hospital, Washington, DC, USA Abstract: Cervical dystonia is the most common form of focal dystonia characterized by
Mills RR, Pagan FL
doaj  

Characterization of Clostridium botulinum Type B Neurotoxin Associated with Infant Botulism in Japan

, 1998
Shunji Kozaki, Yoichi Kamata, Tei‐ichi Nishiki, Hiroaki Kakinuma, Hiromi Maruyama, Hiroaki Takahashi, Tadahiro Karasawa, Kiyotaka Yamakawa, Shinichi Nakamura   +8 more
openalex   +1 more source

Evaluation of the Therapeutic Usefulness of Botulinum Neurotoxin B, C1, E, and F Compared with the Long Lasting Type A [PDF]

, 2003
Patrick Foran, Nadiem Mohammed, Godfrey Lisk, Sharuna Nagwaney, Gary W. Lawrence, Eric A. Johnson, Leonard A. Smith, K. Roger Aoki, J. Oliver Dolly   +8 more
openalex   +1 more source

Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache

Neurology, 2016
D. Simpson, M. Hallett, E. Ashman, C. Comella, Mark W. Green, G. Gronseth, M. Armstrong, D. Gloss, S. Potrebic, J. Jankovic, B. Karp, M. Naumann, Y. So, S. Yablon   +13 more
semanticscholar   +1 more source

Production and Purification of the Heavy Chain Fragment C of Botulinum Neurotoxin, Serotype A, Expressed in the Methylotrophic Yeast Pichia pastoris

, 2000
Karen J. Potter, Wenhui Zhang, Leonard A. Smith, Michael M. Meagher   +3 more
openalex   +2 more sources

Botulinum neurotoxin to treat chronic anal fissure: results of a randomized ‘Botox vs. Dysport’ controlled trial [PDF]

, 2004
Giuseppe Brisinda, Alberto Albanese, Federica Cadeddu, Anna Rita Bentivoglio, A. Mabisombi, Gaia Marniga, G. Maria   +6 more
openalex   +1 more source

ModelingPichia pastoris growth on methanol and optimizing the production of a recombinant protein, the heavy-chain fragment C of botulinum neurotoxin, serotype A

, 2000
Wenhui Zhang, Mark A. Bevins, Bradley A. Plantz, Leonard A. Smith, Michael M. Meagher   +4 more
openalex   +2 more sources

Sonoanatomy of the Nasal Ala for Botulinum Neurotoxin Injection. [PDF]

J Cosmet Dermatol
Yi KH, Kim SB, Hu H, Frank K, Cartier H, Garson S, Kim HJ.   +6 more
europepmc   +1 more source

Thearubigins counteract the toxic effects of botulinum neurotoxins

, 2000
Eiki Satoh, Toshiaki Ishii, Yoshio Shimizu, Shin‐ichi Sawamura, Masakazu Nishimura   +4 more
openalex   +1 more source

Synaptotagmins I and II Act as Nerve Cell Receptors for Botulinum Neurotoxin G [PDF]

, 2004
Andreas Rummel, Tino Karnath, Tina Henke, Hans Bigalke, Thomas Binz   +4 more
openalex   +1 more source